Advances in early diagnosis of hepatocellular carcinoma

• 作者: Partha Pratim Bose Urmimala Chatterjee
• 来源期刊: 肝癌研究（英文版）
• 年，卷（期）: 2019,（7）
• 所属期刊栏目: Review
• 页码范围: 9-17
• 页数: 9页
• 语种: 英文
• DOI: 10.20517/2394-5079.2019.10

摘要

Hepatocellular carcinoma (HCC) is the most recurrent hepatic malignancy and the third in the cancer-related casualties in the west. The frequently-documented causes of HCC are chronic liver infections by hepatitis B virus or hepatitis C virus, nonalcoholic fatty liver disease, cirrhosis, exposure to aflatoxins and tobacco smocking, etc. Clinical presentation of this fatal disease ranges from asymptomatic to upper abdominal pain or common health conditions like weight loss or lethargy. Among current surveillance strategy for suspected patients, liver imaging and serum alpha fetoprotein estimation has been regularly recommended. However, sensitivity of this diagnostic methodology especially in early detections, often suffers from compromised sensitivity and selectivity. Various image based and serological biomarkers for HCC has been introduced in recent decades with varied sensitivity as stand-alone or combined diagnostic protocol. The current article will review the status of HCC diagnosis with respect to common diagnostic protocol, and upcoming novel biomarkers.